title: Immune mechanisms in polymyositis and dermatomyositis and potential targets for therapy.
abstract: PM and DM are characterized clinically by weakness and low endurance of skeletal muscle. Other organs are frequently involved, suggesting that idiopathic inflammatory myopathies (IIMs) are systemic inflammatory diseases. Involvement of immune mechanisms in IIMs is supported by the presence of T cells, macrophages and dendritic cells in muscle tissue, by the presence of autoantibodies and by HLA-DR being a strong genetic risk factor. T cells may have direct and indirect toxic effects on muscle fibres, causing muscle fibre necrosis and muscle weakness, but the target of the immune reaction is not known. A newly identified T cell subset, CD28(null) T cells, may have cytotoxic effects in the CD4(+) and CD8(+) T cell phenotype. These cells are apoptosis resistant and may contribute to treatment resistance. Several myositis-specific autoantibodies have been identified, but they are all directed against ubiquitously expressed autoantigens and the specificity of the T cell reactivity is not known. These autoantibodies are associated with distinct clinical phenotypes and some with distinct molecular pathways; e.g. sera from patients with anti-Jo-1 autoantibodies may activate the type I IFN system and these sera also contain high levels of B cell activating factor compared with other IIM subsets. The characterization of patients into subgroups based on autoantibody profiles seems to be a promising way to learn more about the specificities of the immune reactions. Careful phenotyping of infiltrating immune cells in muscle tissue before and after specific therapies and relating the molecular findings to clinical outcome measures may be another way to improve knowledge on specific immune mechanism in IIMs. Such information will be important for the development of new therapies.
authors: CMM Foundation, Karolinska University Hospital L8:04, 171 76 Stockholm, Sweden. paulius.venalis@ki.se.
authors: Paulius
authors: P
authors: Venalis
authors: Ingrid E
authors: IE
authors: Lundberg
mesh_terms: D001323:Autoantibodies / Q000097:blood; D003882:Dermatomyositis / Q000276:immunology* / Q000628:therapy*; D006801:Humans; D007167:Immunotherapy; D018908:Muscle Weakness / Q000276:immunology / Q000473:pathology; D018482:Muscle, Skeletal / Q000473:pathology; D017285:Polymyositis / Q000276:immunology* / Q000628:therapy*; D013601:T-Lymphocytes / Q000473:pathology
chemical_list: D001323:Autoantibodies
keywords: adaptive immunity; anti-Jo-1; antisynthetase autoantibodies; cytotoxic T cells; dermatomyositis; immunotherapies; interstitial lung disease; polymyositis